The United Laboratories International Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ULIHF research report →
Price Chart
About the company
The United Laboratories International Holdings Limited functions as a pharmaceutical investment holding company, overseeing the entire spectrum of drug-related activities from initial research and development to manufacturing, distribution, and sales. Its business operations are structured into three main divisions: Bulk Medicine, Intermediate Products, and Finished Products. The company offers a diverse portfolio of medicinal products, including oral and injectable antibiotics, anti-cold and cough remedies, ophthalmic treatments, antiviral drugs, solutions for hepatitis B and diabetes, external dermatological preparations, cardiovascular, cerebrovascular, and nervous system medications, as well as vitamins.
- CEO
- Hoi Shan Tsoi
- IPO
- 2014
- Employees
- 18,000
- HQ
- Yuen Long, HK
Get TickerSpark's AI analysis on ULIHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.44B
- P/E
- 6.57
- Fwd P/E
- 1.95
- PEG
- -0.30
- P/S
- 1.11
- P/B
- 0.84
- EV/EBITDA
- 3.00
- Div Yield
- 3.43%
- Gross Margin
- 41.74%
- Op Margin
- 17.21%
- Net Margin
- 15.79%
- ROE
- 12.65%
- ROIC
- 8.15%
Latest fiscal year · YoY change
- Revenue
- $12.87B-6.5%
- Gross Profit
- $5.37B-11.7%
- Op Income
- $2.21B
- Net Income
- $2.03B-23.6%
- EPS
- $1.05-28.1%
- OCF Growth
- +17.2%
- FCF Growth
- -35.6%
- 52W High
- $2.28
- 52W Low
- $1.18
- 50D MA
- $1.24
- 200D MA
- $1.52
- Beta
- 0.29
- RSI (14)
- 32
- Avg Volume
- 48
No earnings-call transcripts are available for ULIHF yet.
- Free Float
- 56.8%
- Shares Outstanding
- 1.97B
- Float Shares
- 1.12B
Held by 1 ETFs
Biggest fund positions in ULIHF by dollar value.
Our ULIHF coverage
Recent articles, reports, and earnings notes.
No research on ULIHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ULIHF report →